Panacea Pharmaceuticals, Inc. Announces Collaboration with Massachusetts Institute of Technology Utilizing Breakthrough Technology for Engineering Ultra Affinity Antibodies
(Business Wire)..., which have demonstrated that the overexpression of AAH leads to the transformation of normal cells to cancer cells in liver, brain, colon, pancreatic, and breast cancers......., oligodendroglioma, and primitive neuroectodermal tumors have shown a marked overexpression of AAH....- Feb 07 10:03 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010207/md_panacea.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines